Abstract
Abstract
Background
Chagas disease is caused by the haemoflagellate protozoan Trypanosoma cruzi. Currently, T. cruzi recognizes seven discrete typing units (DTUs): TcI to TcVI and Tcbat. The genetic diversity of T. cruzi is suspected to influence the clinical outcome. Acute clinical manifestations, which include myocarditis and meningoencephalitis, are sometimes fatal; occur most frequently in children and in immunocompromised individuals. Acute disease is often overlooked, leading to a poor prognosis.
Case presentation
A 38-year-old man from a subtropical area of the Andes mountains of Ecuador was hospitalized after 3 weeks of evolution with high fever, chills, an enlarged liver, spleen, and lymph nodes, as well as facial edema. ECG changes were also observed. T. cruzi was identified in blood smears, culture and amplification of DNA by PCR. Tests for anti-T. cruzi IgG and IgM and HIV were negative. Molecular typing by restriction fragment length polymorphism (PCR-RFLP) determined the parasite to DTU TcI. In the absence of a timely anti-T. cruzi medication, the patient died.
Conclusions
This is a case of severe pathogenicity and the virulence of a DTU TcI strain in an adult patient. The severe acute Chagas disease was probably overlooked due to limited awareness and its low incidence. Our findings suggest that T. cruzi DTU TcI strains circulating in Ecuador are capable of causing fatal acute disease. Early diagnosis and prompt treatment is of paramount importance to avoid fatalities in acute infections.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. World Health Organization. Chagas disease (American trypanosomiasis). Geneva: World Health Organization Washington; 2018. Accessed 19 June 2018: http://www.who.int/news-room/fact-sheets/detail/ chagas-disease (american-trypanosomiasis)
2. Messenger LA, Miles MA, Bern C. Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease. Expert Rev Anti Infect Ther. 2015;13(8):995–1029. https://doi.org/10.1586/14787210.2015.1056158.
3. Zingales B. Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity. Acta Trop. 2018;184:38–52.
4. Costales JA, Jara-Palacios MA, Llewellyn M, Messenger LA, Ocaña-Mayorga S, Villacís AG. Trypanosoma cruzi population dynamics in the Central Ecuadorian Coast. Acta Trop. 2015;151:88–93.
5. Diaz-Bello Z, Thomas MC, Lopez MC, Zavala-Jaspe R, Noya O, Alarcón de Noya B. Trypanosoma cruzi genotyping supports a common source of infection in a school-related oral outbreak of acute Chagas disease in Venezuela. Epidemiol Infect. 2014;142(1):156–62.